Greg Tourangeau

Insider Reports History

Entity
Individual
Location
C/O Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA
Signature
/s/ Gregory Tourangeau
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Greg Tourangeau:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Principal Accounting Officer Common Stock 11.6K $89.8K $7.76 May 7, 2024 Direct
Fulcrum Therapeutics, Inc. Principal Accounting Officer Stock Option (right to buy) 76.1K Jan 24, 2025 Direct

Insider Reports Filed by Greg Tourangeau

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FULC Fulcrum Therapeutics, Inc. Jan 24, 2025 1 $0 4 Jan 28, 2025 Principal Accounting Officer
FULC Fulcrum Therapeutics, Inc. May 7, 2024 1 -$1.83K 4 May 9, 2024 Principal Accounting Officer
FULC Fulcrum Therapeutics, Inc. Mar 8, 2024 1 -$57.2K 4 Mar 8, 2024 Vice President, Finance
FULC Fulcrum Therapeutics, Inc. Jan 26, 2024 2 $0 4 Jan 30, 2024 Vice President, Finance
FULC Fulcrum Therapeutics, Inc. May 10, 2023 1 -$695 4 May 11, 2023 Principal Accounting Officer
FULC Fulcrum Therapeutics, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Controller
FULC Fulcrum Therapeutics, Inc. Jul 15, 2022 1 $0 4 Jul 19, 2022 Controller
FULC Fulcrum Therapeutics, Inc. May 6, 2022 2 $0 4 May 10, 2022 Controller
FULC Fulcrum Therapeutics, Inc. Mar 11, 2022 0 $0 3 Mar 14, 2022 Controller